Stage Iii Pancreatic Cancer: Disease Bioinformatics
Pancreatic Cancer is an aggressive and quickly spreading disease where few symptoms exist until the cancer is very advanced, and because of this, pancreatic cancer has a poor prognosis even with early detection. It occurs when malignant cells form in the tissues of the pancreas, typically in the exocrine cells (the cells that produce digestive juices). Pancreatic cancer typically affects individuals who are African American, who are overweight, have diabetes, smoke, have pancreatitis, or have a family history of pancreatic cancer. Treatments for pancreatic cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials. Stage III pancreatic cancer occurs when the tumor is growing outside of the pancreas into large blood vessels or major nerves, as well as perhaps into nearby lymph nodes. At this point, it has not spread to distant locations.
Stage Iii Pancreatic Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Pancreatic Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1102 products for the study of Stage Iii Pancreatic Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.